The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemia

被引：3
作者：
Pecorelli, S [1 ]
机构：
[1] Univ Brescia, Dept Gynecol Oncol, Brescia, Italy
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 03期
关键词：
D O I：
10.1053/sonc.2002.33527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 15
页数：3
相关论文
共 24 条
[1]   TRILINEAGE RECOVERY BY COMBINATION THERAPY WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (RHG-CSF) AND ERYTHROPOIETIN (RHEPO) IN SEVERE APLASTIC-ANEMIA [J].
BESSHO, M ;
TOYODA, A ;
ITOH, Y ;
SAKATA, T ;
KAWAI, N ;
JINNAI, I ;
SAITO, M ;
HIRASHIMA, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (03) :409-411
[2]  
BUSH RS, 1996, INT J RADIAT ONCOL, V12, P2047
[3]   RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR ANEMIC CANCER-PATIENTS ON COMBINATION CHEMOTHERAPY [J].
CASE, DC ;
BUKOWSKI, RM ;
CAREY, RW ;
FISHKIN, EH ;
HENRY, DH ;
JACOBSON, RJ ;
JONES, SE ;
KELLER, AM ;
KUGLER, JW ;
NICHOLS, CR ;
SALMON, SE ;
SILVER, RT ;
STORNIOLO, AM ;
WAMPLER, GL ;
DOOLEY, CM ;
LARHOLT, KM ;
NELSON, RA ;
ABELS, RI .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (10) :801-806
[4]   Use of recombinant human erythropoietin outside the setting of uremia [J].
Cazzola, M ;
Mercuriali, F ;
Brugnara, C .
BLOOD, 1997, 89 (12) :4248-4267
[5]  
CLEELAND CS, 1999, P AN M AM SOC CLIN, V18, pA574
[6]   Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia [J].
DelMastro, L ;
Venturini, M ;
Lionetto, R ;
Garrone, O ;
Melioli, G ;
Pasquetti, W ;
Sertoli, MR ;
Bertelli, G ;
Canavese, G ;
Costantini, M ;
Rosso, R .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2715-2721
[7]   Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].
Demetri, GD ;
Kris, M ;
Wade, J ;
Degos, L ;
Cella, D .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425
[8]  
DEMETRI GD, 1999, BIENN M INT GYN CANC
[9]  
Doweiko J P, 1991, Oncology (Williston Park), V5, P31
[10]   Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing [J].
Gabrilove, JL ;
Cleeland, CS ;
Livingston, RB ;
Sarokhan, B ;
Winer, E ;
Einhorn, LH .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2875-2882
123